1. Home
  2. CYTK

CYTK

Cytokinetics Incorporated

Logo Cytokinetics Incorporated

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Founded: 1997 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 7.8B IPO Year: 2004
Target Price: $80.53 AVG Volume (30 days): 2.2M
Analyst Decision: Strong Buy Number of Analysts: 15
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.45 EPS Growth: N/A
52 Week Low/High: $25.98 - $110.25 Next Earning Date: 05-02-2024
Revenue: $7,530,000 Revenue Growth: -92.04%
Revenue Growth (this year): -13.21% Revenue Growth (next year): 2168.09%

Share on Social Networks: